GlassScriptPhysician profile
Cuong D Nguyen
NPI 1184714412
$8,484.00
in general payments reported to CMS, 2019-2025
13 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $937 · 2020: $223 · 2021: $1,287 · 2022: $605 · 2023: $2,676 · 2024: $1,477 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,527 · Travel and Lodging: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,526.69 |
| Travel and Lodging | $905.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,263.57 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,299.46 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Relievant Medsystems, INC. | $1,228.96 | 2022-2023 | Intracept |
| Saluda Medical Americas, INC. | $639.55 | 2024-2025 | Evoke |
| Biotronik Nro, INC. | $520.96 | 2024-2025 | Prospera |
| Abbott Laboratories | $433.72 | 2019-2020 | |
| Medtronic USA, INC. | $232.71 | 2019 | |
| Electronic Waveform Lab, INC. | $223.00 | 2023-2024 | |
| Spr Therapeutics, INC | $190.07 | 2023 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $146.26 | 2023-2024 | Iovera |
| Nevro Corp. | $143.42 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $115.63 | 2025 | |
| Bioventus LLC | $46.69 | 2024 | Stimrouter Implantable Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cuong Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.